Disease/Infection News

RSS

Controlled TB vaccine trial designed to study prevention of Mtb infection by vaccination

Aeras today announced the initiation of the first randomized, controlled tuberculosis (TB) vaccine trial designed to study prevention of Mycobacterium tuberculosis (Mtb) infection by vaccination.

11 Mar 2014

Study gives insights into designing new drugs to fight infections

Efforts to combat bacteria’s growing resistance to antibiotics could be helped by a key discovery about the complex processes that enable bugs to thrive.

10 Mar 2014

Findings suggest that IBS is linked to detectable gut microbiota alterations

Irritable bowel syndrome (IBS) belongs to the most widespread diseases in Western countries, causing up to sixty per cent of the workload of gastrointestinal physicians. One of the most frequent symptoms of IBS is bloating, which reduces quality of life considerably as patients perceive it as particularly bothersome.

10 Mar 2014

Inconsistent definition and management of deadly pathogens could contribute to spread of infections

Infection control practices for detecting and treating patients infected with emerging multidrug-resistant gram-negative bacteria (MDR-GNB) vary significantly between hospitals.

10 Mar 2014

Warmer temperatures allow malaria to spread to higher elevations

Malaria, a mosquito-borne disease, infects more than 300 million people each year. Cooler highland regions have historically provided havens from malaria, but it has been predicted that the disease could be especially sensitive to climate change, since both the Plasmodium parasites that cause it and the Anopheles mosquitoes that spread it thrive at warm temperatures. The potential impact of global warming on the worldwide incidence of malaria has been debated for more than two decades.

7 Mar 2014

New method of protecting women from transmission of HIV is safe

Findings of an early phase clinical trial at the University of Alabama at Birmingham suggest that a possible new method of protecting women from the transmission of HIV is safe.

7 Mar 2014

Researchers look at health threat to pregnant women with history of Kawasaki disease

In the first study of its type, researchers at the University of California, San Diego School of Medicine have looked at the health threat to pregnant women with a history of Kawasaki disease (KD), concluding that the risks are low with informed management and care.

7 Mar 2014

Boehringer Ingelheim reports results from SVR12 Phase 3 trial in patients with HCV/HIV co-infection

Today Boehringer Ingelheim announced results from STARTVerso4 in patients with HCV/HIV co-infection. Hepatitis C viral cure 12 weeks after the conclusion of treatment (SVR12) was achieved by 72% of all patients in the trial. Patients were enrolled in either 120mg or 240mg faldaprevir dose groups.

6 Mar 2014

Researchers awarded $26M NIH grant to advance treatments for Ebola and Marburg

The University of Texas Medical Branch at Galveston, Profectus Biosciences, Tekmira Pharmaceuticals and the Vanderbilt University Medical Center have been awarded up to $26 million to advance treatments of the highly lethal hemorrhagic fever viruses Ebola and Marburg.

6 Mar 2014

New drug is effective against superbug MRSA

"I routinely call hospitals and request their yearly antibiotic susceptibility testing data," said Washington University in St. Louis' Timothy Wencewicz. "The log might say, for example, that they've treated hundreds of patients for Acinetobacter baumanni, a bacterium brought into U.S. hospitals by soldiers wounded in the Iraq war, with 30 different antibiotics.

6 Mar 2014

New report reveals recurrent humanitarian crises in Democratic Republic of Congo's eastern provinces

Democratic Republic of Congo is in the grip of an emergency. For two decades, persistent conflict in its eastern provinces and instability in other regions and a dysfunctional health system have led to recurrent humanitarian crises and outbreaks of disease.

6 Mar 2014

Low-dose oral interferon may reduce risk of HCV relapse in patients with mild liver fibrosis

Chronic hepatitis C virus (HCV) infection can lead to serious diseases such as cirrhosis and cancer of the liver, so viral clearance and prevention of relapse are important treatment goals.

6 Mar 2014

Study to understand role of bacterium in heart valve disease

A disease-causing bacterium found in the mouth needs manganese, a trace mineral, in order to cause a serious heart infection, according to a preclinical study led by researchers at Virginia Commonwealth University Philips Institute for Oral Health Research in the School of Dentistry.

6 Mar 2014

Merck announces new data from ongoing C-WORTHY Study in HIV/HCV co-infected patients

Merck, known as MSD outside of the United States and Canada, today announced new data from HIV/HCV co-infected patients in the ongoing C-WORTHY Study, a Phase 2 clinical trial evaluating the efficacy and safety of Merck's all-oral, once-daily regimen combining MK-5172, an investigational hepatitis C virus (HCV) NS3/4A protease inhibitor, and MK-8742, an investigational HCV NS5A replication complex inhibitor.

5 Mar 2014

Haiti HIV program increases sexual health awareness and practices in women

New research from the University of Toronto shows that a little training can go a long way in a desperate situation.

5 Mar 2014

Stock-outs of ARV drugs in Central African Republic impact health of HIV-infected people

According to Pierre-Marie David of the University of Montreal's Faculty of Pharmacy, stock-outs of antiretroviral (ARV) drugs in recent years in the Central African Republic have had a dramatic impact on the health of HIV-infected people.

5 Mar 2014

Small-molecule drug effective in protecting nonhuman primates from lethal Marburg virus

For the first time, scientists have demonstrated the effectiveness of a small-molecule drug in protecting nonhuman primates from the lethal Marburg virus. Their work, published online in the journal Nature, is the result of a continuing collaboration between Army scientists and industry partners that also shows promise for treating a broad range of other viral diseases.

5 Mar 2014

New PhoneSoap Charger is most effective way to kill bacteria growing on cell phones

Cell phones have become our constant companions, and as a result, they are exposed to many bacteria and viruses. When we open a door, shake hands, use an ATM or dozens of other daily tasks, our hands come in contact with germs, and numerous studies have shown that a significant number of bacteria, such as the flu virus, staph, strep, E. coli, and salmonella, are transferred from our hands to our cell phones every time we pick them up.

5 Mar 2014

Researchers develop adjuvant which enhances effect of virus transduction

Lentiviruses, which belong to the family of retroviruses, are used as vectors to exchange genetic material in cells and can be used to replace a defective gene as defined by gene therapy.

5 Mar 2014

Novel HIV prevention products for women demonstrate safety in clinical studies

Two early clinical studies of novel HIV prevention products for women - the first combination antiretroviral (ARV) vaginal ring and a vaginal film - show the products to be safe and open the door to product improvements that could expand options for women-initiated prevention tools. The results of both studies were presented today at the 21st Conference on Retroviruses and Opportunistic Infections.

5 Mar 2014

Disease/Infection News

Controlled TB vaccine trial designed to study prevention of Mtb infection by vaccination

Study gives insights into designing new drugs to fight infections

Findings suggest that IBS is linked to detectable gut microbiota alterations

Inconsistent definition and management of deadly pathogens could contribute to spread of infections

Warmer temperatures allow malaria to spread to higher elevations

New method of protecting women from transmission of HIV is safe

Researchers look at health threat to pregnant women with history of Kawasaki disease

Boehringer Ingelheim reports results from SVR12 Phase 3 trial in patients with HCV/HIV co-infection

Researchers awarded $26M NIH grant to advance treatments for Ebola and Marburg

New drug is effective against superbug MRSA

New report reveals recurrent humanitarian crises in Democratic Republic of Congo's eastern provinces

Low-dose oral interferon may reduce risk of HCV relapse in patients with mild liver fibrosis

Study to understand role of bacterium in heart valve disease

Merck announces new data from ongoing C-WORTHY Study in HIV/HCV co-infected patients

Haiti HIV program increases sexual health awareness and practices in women

Stock-outs of ARV drugs in Central African Republic impact health of HIV-infected people

Small-molecule drug effective in protecting nonhuman primates from lethal Marburg virus

New PhoneSoap Charger is most effective way to kill bacteria growing on cell phones

Researchers develop adjuvant which enhances effect of virus transduction

Novel HIV prevention products for women demonstrate safety in clinical studies

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News